Operating Margin in % of Akebia Therapeutics, Inc. from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Akebia Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to Q3 2025.
  • Akebia Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2025 was 7.88 %.
  • Akebia Therapeutics, Inc. annual Operating Margin for 2024 was -31.5 %, a 32.6% decline from 2023.
  • Akebia Therapeutics, Inc. annual Operating Margin for 2023 was -23.8 %, a 13.9% increase from 2022.
  • Akebia Therapeutics, Inc. annual Operating Margin for 2022 was -27.6 %, a 77.9% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Akebia Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 7.88 +28.4 Jul 1, 2025 Sep 30, 2025
Q2 2025 0.39 +20.6 Apr 1, 2025 Jun 30, 2025
Q1 2025 -11.9 +7.1 +37.3% Jan 1, 2025 Mar 31, 2025
Q4 2024 -31.5 -7.74 -32.6% Oct 1, 2024 Dec 31, 2024
Q3 2024 -20.5 +6.56 +24.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -20.2 +24.5 +54.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -19 -1.73 -10% Jan 1, 2024 Mar 31, 2024
Q4 2023 -23.8 +3.85 +13.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -27 +20.9 +43.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -44.8 +4.73 +9.56% Apr 1, 2023 Jun 30, 2023
Q1 2023 -17.3 +100 +85.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -27.6 +97.4 +77.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -48 +87.5 +64.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -49.5 +80.6 +62% Apr 1, 2022 Jun 30, 2022
Q1 2022 -117 +30.7 +20.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -125 +2.79 +2.18% Oct 1, 2021 Dec 31, 2021
Q3 2021 -136 -10.3 -8.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -130 -17.3 -15.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -148 -71.1 -92.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -128 -42.3 -49.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -125 -38.7 -44.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -113 -24.3 -27.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -76.8 +21.1 +21.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -85.5 +0.3 +0.35% Oct 1, 2019 Dec 31, 2019
Q3 2019 -86.6 Jul 1, 2019 Sep 30, 2019
Q2 2019 -88.5 Apr 1, 2019 Jun 30, 2019
Q1 2019 -97.9 Jan 1, 2019 Mar 31, 2019
Q4 2018 -85.8 Oct 1, 2018 Dec 31, 2018

Akebia Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -31.5 -7.74 -32.6% Jan 1, 2024 Dec 31, 2024
2023 -23.8 +3.85 +13.9% Jan 1, 2023 Dec 31, 2023
2022 -27.6 +97.4 +77.9% Jan 1, 2022 Dec 31, 2022
2021 -125 +3.26 +2.54% Jan 1, 2021 Dec 31, 2021
2020 -128 -42.8 -50% Jan 1, 2020 Dec 31, 2020
2019 -85.5 +0.3 +0.35% Jan 1, 2019 Dec 31, 2019
2018 -85.8 -43.5 -103% Jan 1, 2018 Dec 31, 2018
2017 -42.3 +8.85K +99.5% Jan 1, 2017 Dec 31, 2017
2016 -8.89K Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.